Stopped: No longer studying long COVID
The purpose of this research study is to assess if glutathione, along with NAC (N-acetyl cysteine) and Alpha lipoic acid (ALA), can help reverse some of the COVID long-haul symptoms.Subjects will be randomized in to one of two groups. Depending on the group they are randomized in to, subjects will be taking either a combination of NAC, Alamax CR, and liposomal GSH or the same three nutritional supplements with a multivitamin and magnesium. Regardless of the group, subjects will be asked questions to assess their COVID symptoms, physical and mental health status. They will also be asked to take blood samples.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Assess Changes in Symptoms of Post-Acute Sequelae of COVID (PASC)
Timeframe: Symptoms will be evaluated at 2 weeks, 1-, 2-, 3- and 4 months post therapy
Change in Quality of Life Using SF-36 Survey
Timeframe: Will be evaluated at 2 weeks, 1-, 2-, 3- and 4 months post therapy
COVID Severity of Symptoms Questionnaire
Timeframe: Day 15, 28, end of months 2, 3, 4
Change in Time to Clinical Recovery (TTCR)
Timeframe: Day 15 and 28 (month 1), and at the end of months 2, 3 and 4